Endometrial Cancer
Cancer
Endometrial Cancer is treated with 3 medications in our database, including Keytruda, Hydroxyprogesterone Caproate, Jemperli. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Merck & Co., Covis, GlaxoSmithKline. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Endometrial Cancer treatment below.
What help exists for Endometrial Cancer
4
drugs indexed
3
with copay cards
3
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Endometrial Cancer
4 totalHydroxyprogesterone Caproate
Hydroxyprogesterone Caproate · Covis
🎟💙IMFINZI
Durvalumab
Jemperli
dostarlimab · GlaxoSmithKline
🎟💙KEYTRUDA
pembrolizumab · Merck
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Endometrial Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |